956 (Alfuzosin Extended Release 10 mg)

Pill imprint 956 has been identified as Alfuzosin hydrochloride extended release 10 mg.

Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 956

Alfuzosin hydrochloride extended release 10 mg 956
Alfuzosin hydrochloride extended release
Imprint:
956
Strength:
10 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Caraco Pharmaceutical Laboratories, Ltd.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)